Acute effects of sitagliptin on progenitor cells and soluble mediators in newly diagnosed type 2 diabetes 
.

CONCLUSION: Sitagliptin is able to directly increase the number of peripheral blood EPCs. This direct effect is to be important for lowering vascular risk in early diabetes before macrovascular complications appear. PMID: 32567544 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research